Tyrosine Kinase Inhibitors Immunotherapy Cyclin Dependent Kinase Inhibitors Serine-Threonine Kinase Inhibitors CD Protein Inhibitors Threonine-Tyrosine Kinase Inhibitors | Solid Tumor | Biliary Tract Cancer | Non Small Cell Lung Cancer | Colorectal Cancer | Glioma | Gastrointestinal Stromal Tumor | Small Intestinal Carcinoma | Pancreatic Cancer | Thyroid Gland Papillary Carcinoma | Soft Tissue Sarcoma | Gastroesophageal Junction Adenocarcinoma | Esophageal Cancer | Cervical Cancer | Breast Cancer | Melanoma | Colon Cancer | Hepatocellular Cancer | Ovarian Cancer | Thyroid Gland Anaplastic Carcinoma | Salivary Gland Cancer | Endometrial Cancer | Gastric Cancer | Thyroid Gland Hurthle Cell Carcinoma | Cutaneous Melanoma | Sarcoma | Rectal Cancer | Vulvar Cancer | Glioblastoma | Neuroendocrine Tumor | Ampulla of Vater Carcinoma | Gastrointestinal Cancer | Cholangiocarcinoma | Thyroid Gland Follicular Carcinoma | Pancreatic Adenocarcinoma | Peritoneal Cancer | Fallopian Tube Cancer | Thyroid Gland Carcinoma | CNS Tumor | Neurofibrosarcoma | Fibrosarcoma | Osteosarcoma | Small Cell Lung Cancer | Spindle Cell Sarcoma | Esophageal Squamous Cell Carcinoma | Lung Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
larotrectinib | |||||||||||||||||||||||||||||||||||||||||||||
entrectinib | |||||||||||||||||||||||||||||||||||||||||||||
Trk inhibitor | |||||||||||||||||||||||||||||||||||||||||||||
Immunotherapy | |||||||||||||||||||||||||||||||||||||||||||||
repotrectinib | |||||||||||||||||||||||||||||||||||||||||||||
ICP-723 | |||||||||||||||||||||||||||||||||||||||||||||
entrectinib + abemaciclib | |||||||||||||||||||||||||||||||||||||||||||||
SIM1803-1A | |||||||||||||||||||||||||||||||||||||||||||||
trametinib + entrectinib |